Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Half-year summary of the liquidity contract_June 2013



Half year summary of NATUREX's liquidity contract with NATIXIS


 


Press release

Avignon, July 5th, 2013


 


Pursuant to the liquidity contract granted to NATIXIS regarding NATUREX shares, the following elements were in the liquidity account as of June 30th, 2013:



  • 8,814 NATUREX shares

  • 246,196.20 euros

The following elements appeared on the liquidity account as of December 31st, 2012:



  • 2,357 NATUREX shares

  • 601,658.69 euros

For information, the following elements appeared on the liquidity account at the time of the implementation of the liquidity contract:



  • 923 NATUREX shares

  • 277,801.85 euros 

 


Download our press releases and other publications on www.naturex.com


 


Naturex has been listed on NYSE Euronext Paris, Compartment B (Mid Caps), since October 1996.








NATUREX Total number of shares comprising the share capital: 7,826,565

ISIN FR0000054694



Naturex is a component of the CAC Small and Gaïa indexes.

Naturex is eligible for the "long only" Deferred Settlement Service (SRD).

Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.



SYMBOL: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY

 


About Naturex


Naturex is the global leader in speciality plant-based natural ingredients.

The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.


Naturex's head office is based in Avignon. The company employs more than 1,400 people with high-performance manufacturing operations across 15 sites in Europe (France, Italy, Spain, the United Kingdom, Switzerland, Poland) as well as in Morocco, the United States, Brazil, Australia and India. It also has a global presence through a dedicated network of sales offices in 20 countries (France, Italy, Spain, Morocco, the United Kingdom, Belgium, Germany, Poland, Russia, U.A.E., Thailand, Japan, China, Korea, Australia, the United States, Canada, Brazil, Mexico and India).


Naturex's development is supported by positive underlying trends linked to the fast-growing demand for natural products and its capacity to provide manufacturers customised solutions to meet the requirements of their end consumers. The Group's strength lies in its positioning with specific products which constitute niche markets, supported by strong sourcing capacity and sustained research & development.


 
















Contacts  
Thierry Lambert

Chairman and Chief Executive Officer

Tel.: +33 (0)4 90 23 96 89

[email protected]
Thierry Bertrand Lambert

Chief Financial Officer

Tel.: +33 (0)4 90 23 96 89

[email protected]
Carole Alexandre

Investor Relations

Tel.: +33 (0)4 90 23 78 28

[email protected]
Anne Catherine Bonjour

Actus Finance Press Relations

Tel.: +33 (0)1 53 67 36 93

[email protected]

Information réglementée
Rachat d'actions / contrat de liquidité :

- Information relative au contrat de liquidité

Communiqué intégral et original au format PDF :


http://www.actusnews.com/documents_communiques/ACTUS-0-32706-2013.07.05-summary-of-liquidity-contract_june-2013.pdf

© Copyright Actusnews Wire

Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free



Quelle: Actusnews

Like: 0
Share

Comments